FORUM Pharmaceuticals Inc   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Waltham MA United States (2001)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2008
NCT01556763
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 3)

Aphasia, Primary Progressive (Phase 2)

Central Nervous System Diseases (Phase 2)

Cognitive Dysfunction (Phase 3)

Dementia (Phase 2)

Frontotemporal Dementia (Phase 2)

Liver Diseases (Phase 1)

Nervous System Diseases (Phase 2)

Pick Disease of the Brain (Phase 2)

Psychotic Disorders (Phase 1)

Renal Insufficiency (Phase 1)

Schizophrenia (Phase 3)

Tobacco Use Disorder (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 19
  • # of Trial APIs: 12